Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-03-20

Clinical Trial Update: Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics. [Phase 4]

View source ↗

Summary

An investigator-initiated Phase 4 randomized open-label study comparing Britomar prolonged-release torasemide with Diuver torasemide to assess natriuresis and c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Britomar (torasemide)
  • Diuver (torasemide)

Snippet

Sponsor: Society of Specialists in Heart Failure | Conditions: Arterial Hypertension, Chronic Heart Failure | Phase 4 | Status: UNKNOWN